← back to search

Sebastian Scheich

Goethe University Frankfurt · DE
Area of research
Pathology and Forensic Medicine · Oncology
Research interest
Research interests include Lymphoma Diagnosis and Treatment, Monoclonal and Polyclonal Antibodies Research, HER2/EGFR in Cancer Research, and Acute Myeloid Leukemia Research.
h-index
18
citations
908
works
134
NIH funding
primary concept
email

Recent publications

Inflammatory signaling pathways play a role in SYK inhibitor resistant AML
Scientific Reports 2025cited by 2position: middledoi
Molecular Determinants of Sensitivity to Polatuzumab Vedotin in Diffuse Large B-Cell Lymphoma
Cancer Discovery 2024cited by 27position: middledoi
Molecular targets of glucocorticoids that elucidate their therapeutic efficacy in aggressive lymphomas
Cancer Cell 2024cited by 21position: middledoi
Targeting N-linked Glycosylation for the Therapy of Aggressive Lymphomas
Cancer Discovery 2023cited by 27position: firstdoi
Exceptional Response to BTK Inhibitors in Aggressive Lymphomas Linked to Chronic Selective Autophagy
Blood 2023cited by 1position: middledoi
Breaking the Pump: Targeting the Sodium-Potassium Pump As a Therapeutic Strategy in Acute Myeloid Leukemia
Blood 2022cited by 2position: middledoi
SHMT2 inhibition disrupts the TCF3 transcriptional survival program in Burkitt lymphoma
Blood 2021cited by 47position: middledoi
Proteome activity landscapes of tumor cell lines determine drug responses
Nature Communications 2020cited by 87position: middledoi
Rewiring of B cell receptor signaling by Epstein–Barr virus LMP2A
Proceedings of the National Academy of Sciences 2020cited by 71position: middledoi
Selective inactivation of hypomethylating agents by SAMHD1 provides a rationale for therapeutic stratification in AML
Nature Communications 2019cited by 82position: middledoi
Functional Dominance of CHIP-Mutated Hematopoietic Stem Cells in Patients Undergoing Autologous Transplantation
Cell Reports 2019cited by 60position: middledoi
Comparative proteomics reveals a diagnostic signature for pulmonary head‐and‐neck cancer metastasis
EMBO Molecular Medicine 2018cited by 63position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Thomas Oellerich · Goethe University Frankfurt7 papers (2019–2025)Hubert Serve · Goethe University Frankfurt5 papers (2019–2025)Louis M. Staudt · National Institutes of Health4 papers (2020–2024)George W. Wright · National Institutes of Health3 papers (2020–2024)Jagan Muppidi · National Institutes of Health3 papers (2020–2024)Henning Urlaub · Universitätsmedizin Göttingen2 papers (2020–2024)Constanze Schneider · Broad Institute2 papers (2019–2022)Kimberly Stegmaier · Harvard University2 papers (2022–2025)James D. Phelan · National Institutes of Health2 papers (2024–2024)Kuan‐Ting Pan · Urologische Klinik München2 papers (2020–2024)Tony Hsiao · Center for Cancer Research2 papers (2024–2024)Federico Comoglio · Engene (Brazil)2 papers (2019–2020)Gabriela Alexe · Broad Institute2 papers (2022–2025)Yanlong Ji · Nanjing University of Information Science and Technology2 papers (2020–2024)Björn Häupl · Goethe University Frankfurt2 papers (2022–2024)Vivian M. Morris · National Institutes of Health2 papers (2024–2024)Xin Yu · National Institutes of Health1 papers (2024–2024)Tobias Schmid · Goethe University Frankfurt1 papers (2019–2019)Gesine Bug · German Cancer Research Center1 papers (2019–2019)Olga Buzovetsky · Rockefeller University1 papers (2019–2019)